Savolitinib is a targeted therapy drug indicated for the treatment of non-small cell lung cancer (NSCLC) harboring specific gene mutations (e.g., MET exon 14 skipping mutation). Its price is subject to variations based on factors such as dosage form, region, and medical insurance policies. In the domestic market, the price generally ranges from $$1,500 to$$2,500 per box (200 mg × 21 tablets). The actual price shall be subject to the quotation of hospitals or pharmacies. Patients must use the medication under the guidance of a physician and undergo regular assessments of treatment efficacy and adverse reactions.
Factors Affecting the Price
Dosage Form and Strength
Savolitinib is commonly available in 200 mg and 100 mg tablet strengths, with significant price differences between boxes of different dosages.
Patients need to calculate the monthly medication cost based on the dosage regimen recommended by their physicians (e.g., daily dose).
Medical Insurance Policies
Savolitinib has been included in the medical insurance reimbursement list in some regions, where patients' out-of-pocket ratio may be reduced to 30%–50%.
In regions where the drug is not covered by medical insurance or for patients who do not meet the reimbursement criteria, full self-payment is required.
Purchase Channels
Prices at hospital pharmacies or authorized retail pharmacies are relatively transparent, but may fluctuate due to inventory adjustments.
Vigilance is advised against purchasing drugs through unauthorized channels to avoid counterfeit or substandard products.
Precautions for Medication Use
Strictly Follow Physician's Instructions: Savolitinib is a prescription-only medication. Its applicability must be confirmed by genetic testing results, and the dosage should not be adjusted or the medication discontinued without medical approval.
Adverse Reaction Management: Common adverse reactions include edema, nausea, and abnormal liver function. Regular follow-up examinations are required, and any discomfort should be promptly communicated with the attending physician.
Financial Assistance: Some charitable organizations or pharmaceutical companies offer patient assistance programs. Eligible patients may consult their attending physicians or relevant platforms for application procedures.
Medical Guidance
For patients who need to take Savolitinib, the following recommendations are provided:
Visit the Department of Oncology or Department of Respiratory Medicine in a formal hospital and complete genetic testing to confirm the mutation type.
Conduct in-depth communication with physicians regarding the treatment plan, associated costs, and medical insurance policies. Seek multidisciplinary consultation when necessary.
Undergo regular imaging examinations and blood tests during the medication period to evaluate treatment efficacy and safety.
Price information is subject to dynamic changes. It is recommended to obtain the latest updates through hospitals or official channels.
